MASI
NGSMasimo Corporation
Healthcare•Medical Instruments & Supplies
Watchlists:
Last updated: Friday 18th July 2025
158.35
-1.10 (-0.69%)
Prev Close:159.45
Open:158.58
Bid:155.51
Ask:161.96
52 Week Range
101.61194.88
Volume:609,250
Mkt Cap:8,677 M
37
MarketXLS Rank ®
Weak Hold
Price Target
$182.10
+15.0%
Financial Statements
MASI - Income Statement (Annual)
| Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cumulative Effect Of Accounting Change | 439000.0 | -27 M | ||||||||
| Depreciation And Amortization | 25 M | 22 M | 19 M | -16 M | -15 M | -13 M | -12 M | |||
| Earnings From Equity Interest | 13 M | |||||||||
| Earnings From Equity Interest Net Of Tax | 13 M | |||||||||
| Gain On Sale Of Security | 37 M | |||||||||
| General And Administrative Expense | 744 M | 664 M | 657 M | 395 M | 369 M | 315 M | -7 M | -7 M | -5 M | -5 M |
| Gross Profit Margin (profit Margin After CGS) | 1,004 M | 1,004 M | 1,059 M | 808 M | 743 M | 629 M | 575 M | 522 M | 478 M | 410 M |
| Impairment Of Capital Assets | 304 M | 10 M | -400000.0 | |||||||
| Interest Expense Non Operating | 44 M | 50 M | 26 M | 300000.0 | 300000.0 | 328000.0 | -706000.0 | -678000.0 | -3 M | -3 M |
| Interest Expense Operating | -300000.0 | -270000.0 | -211000.0 | -193000.0 | -551000.0 | -4 M | -2 M | |||
| Minority Interests | 1,408 M | 1,168 M | -297000.0 | 2 M | ||||||
| Misc Other Special Charges | -39 M | -48 M | -17 M | -1 M | 8 M | 13 M | 2 M | 738 M | 110000.0 | 61000.0 |
| Net Income (loss) | -305 M | 82 M | 144 M | 230 M | 240 M | 196 M | 194 M | 136 M | 287 M | 83 M |
| Net Income Common Stockholders | -305 M | 82 M | 144 M | 230 M | 240 M | 196 M | 194 M | 136 M | 287 M | 83 M |
| Net Income Continuous Operations | -305 M | 82 M | 144 M | 230 M | 240 M | 196 M | 194 M | 136 M | 287 M | 83 M |
| Net Non Operating Interest Income Expense | -39 M | -47 M | -24 M | 600000.0 | 5 M | 14 M | 6 M | 2 M | -2 M | -4 M |
| Non Recurring Operation Expense | 500000.0 | 18 M | -474000.0 | 425000.0 | -270 M | -20 M | ||||
| Operating Income | -267 M | 137 M | 210 M | 276 M | 256 M | 221 M | 208 M | 116 M | 151 M | 101 M |
| Operating Income Before Depreciation (EBITDA) | -157 M | 239 M | 357 M | 310 M | 293 M | 258 M | 234 M | 205 M | 428 M | 126 M |
| Operating Expense | 1,271 M | 867 M | 849 M | 533 M | 487 M | 408 M | 366 M | -338 M | -43 M | 309 M |
| Other Gand A | 744 M | 664 M | 657 M | 395 M | 369 M | 315 M | -7 M | -7 M | -5 M | -5 M |
| Other Operating Expenses | -7 M | -7 M | -3 M | -3 M | 68 M | -43 M | -290 M | |||
| Other Taxes | 300000.0 | 300000.0 | 300000.0 | -300000.0 | -400000.0 | -400000.0 | -400000.0 | |||
| Promotion And Advertising | 9 M | 31 M | 14 M | -18 M | -18 M | -11 M | -11 M | |||
| Realized Capital Gain | 79 M | |||||||||
| Rent And Landing Fees | -7 M | -7 M | -5 M | -5 M | ||||||
| Research Expense | 223 M | 175 M | 191 M | 137 M | 119 M | 93 M | 81 M | 62 M | 59 M | 57 M |
| Salaries And Wages | -16 M | -30 M | -16 M | -27 M | -39 M | -16 M | -11 M | |||
| Selling And Marketing Expense | 9 M | 31 M | 14 M | 285 M | 276 M | 254 M | 253 M | |||
| Selling Expense | 285 M | 276 M | 254 M | 253 M | ||||||
| Total Income Available For Interest Expense (EBIT) | -262 M | 138 M | 219 M | 275 M | 264 M | 234 M | 213 M | 185 M | 411 M | 111 M |
| Total Revenues | 2,094 M | 2,048 M | 2,036 M | 1,239 M | 1,144 M | 938 M | 858 M | 790 M | 695 M | 630 M |
| Total Expenses | 2,361 M | 1,912 M | 1,826 M | 963 M | 888 M | 717 M | 650 M | -606 M | -274 M | 529 M |
| Total Revenue | 2,094 M | 2,048 M | 2,036 M | 1,239 M | 1,144 M | 938 M | 858 M | 790 M | 713 M | 630 M |
| Write Off | 63 M | |||||||||
| Amord | 100 M | 103 M | 22 M | -4 M | -4 M | -100000.0 | -200000.0 | |||
| Avgshs | 53 M | 53 M | 54 M | 55 M | 55 M | 53 M | 52 M | 52 M | 50 M | 51 M |
| Avgshsdt | 53 M | 54 M | 55 M | 58 M | 58 M | 57 M | 56 M | 56 M | 53 M | 54 M |
| Basiceps | -5.72 | 1.54 | 2.68 | 4.16 | 4.39 | 3.67 | 3.7 | 2.42 | 6.07 | 1.62 |
| Basicepscont | -5.72 | 1.54 | 2.68 | 4.16 | 4.39 | 3.67 | ||||
| Cor | 1,090 M | 1,045 M | 977 M | 431 M | 401 M | 309 M | 283 M | -268 M | -231 M | 220 M |
| Depamor | 25 M | 22 M | 19 M | -16 M | -15 M | -13 M | -12 M | |||
| Dileps | -5.72 | 1.51 | 2.6 | 3.98 | 4.14 | 3.44 | 3.45 | 2.23 | 5.65 | 1.55 |
| Dilepscont | -5.72 | 1.51 | 2.6 | 3.98 | 4.14 | 3.44 | ||||
| Intinc | 5 M | 3 M | 2 M | 900000.0 | 6 M | 14 M | 6 M | 2 M | -2 M | -4 M |
| Netincdisc | -305 M | 82 M | 144 M | 230 M | 240 M | 196 M | 194 M | 136 M | 287 M | 83 M |
| Othincexp | 39 M | 48 M | 17 M | 1 M | -8 M | -13 M | -2 M | -79 M | -50 M | -61000.0 |
| Pretaxinc | -305 M | 88 M | 193 M | 274 M | 264 M | 234 M | 214 M | 186 M | 418 M | 116 M |
| Resdev | 223 M | 175 M | 191 M | 137 M | 119 M | 93 M | 81 M | 62 M | 59 M | 57 M |
| Sga | 744 M | 664 M | 657 M | 395 M | 369 M | 315 M | 285 M | 276 M | 254 M | 253 M |
| Shsout | 54 M | 53 M | 53 M | 55 M | 55 M | 54 M | 53 M | 52 M | 50 M | 49 M |
| Specincchg | -304 M | -28 M | 474000.0 | -425000.0 | 400000.0 | 207 M | 20 M | |||
| Taxprov | -400000.0 | 7 M | 50 M | 45 M | 23 M | 38 M | 20 M | 61 M | 118 M | 35 M |